Branded and clinically studied ingredients

Branded ingredients at the dose the research used

For premium wellness brands, we build custom supplements around branded ingredients and clinically studied ingredients, and make them in our Leicester facility as capsules, tablets, softgels, gummies, powders, drinks, liquids, shots and oral pouches. We do the work that lets a brand use the evidence: matching the material, dose and pattern of use in the research, securing the licence, keeping the documents and setting out what each market's label can say. You keep the formula, its specification, the evidence review and the stability data that show the studied dose holds in your format, and every batch comes with a certificate of analysis that reports the branded active against its label amount.

Branded ingredients give a formula what a generic often cannot: a defined material, a documentation pack and, in many cases, human studies run on that exact material. A clinically studied ingredient earns its place only when the product matches the research: the same material, at the same dose, in a format that delivers it. Every project runs through our research and development process, which checks the evidence and the licence terms before formulation starts.

How we check clinically studied ingredients against the trial

Matching the dose used in the research

For every active, we answer in writing the questions the US Federal Trade Commission's Health Products Compliance Guidance asks: how the dosage and formulation compare to the product studied, whether the ingredients are the same, whether the product is taken the same way, and whether the study population reflects the buyers targeted. Four traps recur:

• Compound or element. EFSA found magnesium L-threonate safe for adults at up to 3,000 mg a day of the compound, which supplies about 250 mg of magnesium. Confusing the two misses the dose twelvefold.
• Molecule or salt. The authorised creatine claim needs 3 g of creatine a day, which is 3.41 g of creatine monohydrate, and branded creatine sells on purity, with limits for creatinine and dicyandiamide (see creatine supplement manufacturing).
• Extract or strain. A trial on one extract, made with one solvent and standardised to one marker, does not transfer to another extract of the same plant. Some probiotic benefits are strain-specific, so we specify the strain studied.
• Capsule or gummy. Heat, acid and water in a gummy or drink can change an ingredient that was stable in the trial's capsules, so we prove the dose survives your format.

Identity: the trial material is your material

We test the identity of every lot of a branded ingredient before use. US supplement rules require at least one appropriate identity test on every dietary ingredient, and allow reliance on a supplier's certificate of analysis for other specifications only once the supplier is qualified. We apply that standard to every product we make, whatever the market. An HPTLC fingerprint against an authenticated reference confirms a botanical extract, HPLC measures the marker compounds the studies were standardised to, FTIR confirms single compounds, and genome or strain-specific data confirm a probiotic strain.

Three kinds of protection behind a branded ingredient

Branded and patented supplement ingredients are protected in up to three ways.

For magnesium L-threonate, only the applicant's material can be used until 7 November 2029 in the EU and until March 2031 in GB.

Using the name and logo on pack

In the UK, a trade mark licence takes effect only in writing, signed for the owner, and it can limit how and on which goods the mark is used. Licences and brand guidelines typically set the amount per serving that earns the name, the wording, the logo artwork and a sign-off before print. We collect that permission before label design, keep the signed-off artwork with your product records and check the licensed name against it at label verification on every batch. The label should never suggest the owner endorses your brand.

Cost against evidence

A branded ingredient usually costs more than a generic version of the same compound. The premium buys a defined material, documents, a recognised name and one accountable supplier, and it pays back only where the evidence can be used. So we ask: does the studied dose fit your serving, will your markets allow a supporting claim, and will the licence let you name the ingredient? Where the answers fall short, a well-specified generic with an authorised nutrient claim is the stronger product, and we say so.

The rules that decide what the evidence can do

United States. A dietary ingredient not marketed in the US before 15 October 1994 needs a new dietary ingredient notification to FDA before it enters interstate commerce, unless it has been in the food supply in a form not chemically altered. GRAS is the route for substances in foods and drinks, not for dietary ingredients in supplements; FDA has proposed making GRAS notices mandatory, with limited exceptions, so we document the GRAS basis of every ingredient in a US food or drink. Structure/function claims carry FDA's disclaimer and a notification. The FTC expects competent and reliable scientific evidence, generally randomised controlled human trials, and at least the level of support a claim states; its guidance reads even "clinically tested ingredient" as a claim that the tests prove a benefit the product delivers.

Great Britain and the EU. Ingredients not consumed to a significant degree before 15 May 1997 need novel food authorisation. Any wording that "states, suggests or implies" a relationship between an ingredient and health is a health claim, so a trial result reaches the label only through an authorised claim and its conditions of use. Botanical claims remain on hold, and in the EU, on-hold claims on psychological or behavioural functions cannot be used, outside a narrow transitional rule. Our claims and regulation review maps this for each market before artwork, and our supplement regulation watch tracks the changes.

Where supplements meet pharma

Branded ingredients sit closest to medicines. In the US, an article approved as a new drug, or authorised for investigation as one with substantial clinical investigations made public, is excluded from dietary supplements unless it was sold as a supplement or food first. We check that boundary before formulation.

Six documents per ingredient and an identity test per lot

Every branded ingredient enters our system with a document file. Every batch is tested by accredited partner laboratories (ISO/IEC 17025) as part of every order, and quality control releases each batch against its specification.

Beyond identity and assay, we and our partner network screen lead, cadmium, mercury and arsenic by ICP-MS and run microbiology, including viable counts for probiotics. Stability studies in the final pack confirm the branded active holds its declared amount through shelf life; our stability and shelf life testing page explains how we set overages from measured losses. Three retained samples of every batch, kept for shelf life plus one year, let us answer any question from the material itself.

From goods-in to batch release

1. Goods-in. Each lot is checked against its specification and certificate, and held until its identity test passes.
2. Dispensing. We weigh the branded ingredient against the batch record, with the overage set in development, so every batch carries the studied amount.
3. Production. Blending, filling or cooking follows the process proven at pilot scale, with in-process weight and uniformity checks.
4. Finished batch. The branded active is assayed against its label amount, alongside every other test in your specification.
5. Release and records. Quality control releases the batch, and the batch record links each lot of the branded ingredient to your finished batch.

Capsule or gummy: what changes for a branded active

Minerals: a protected form and a claim gap

Magnesium L-threonate is a permitted form of magnesium in food supplements in GB and the EU, for adults, excluding pregnant and lactating women. A 2024 randomised trial used 1 g a day of the compound (Hausenblas and colleagues, Sleep Medicine: X). No authorised claim links magnesium to sleep in GB or the EU, so the label uses register claims such as "Magnesium contributes to normal psychological function" on a product that is at least a source of magnesium. See magnesium supplement manufacturing.

What changes by format

Illustrative worked example: a branded extract in a gummy

This example is illustrative, not a client project. A brand wants a gummy built around a branded botanical extract studied in capsules at 300 mg a day. If the licence requires the full studied amount per serving to use the name, two gummies carry 150 mg each. Bench samples take the extract through the cook, with HPLC assay of its markers before and after; if the marker falls, we add the extract later, adjust the pH or set an overage from the measured loss. In GB and the EU, the label pairs the extract with a vitamin carrying an authorised claim. In the US, a structure/function claim can draw on the trials once the substantiation file shows the gummy delivers the studied extract at the studied dose, and that experts would not expect a trial of the gummy itself.

Seven steps, with updates continuing after launch

1. Brief. The ingredient, the claim you want, your markets and your format.
2. Evidence review. Studies matched for form, dose, pattern of use and population, with the claims each market allows.
3. Supplier and licence check. The document file, licence terms, supply security and any data protection end date.
4. Formulation, bench samples and stability. The studied dose in your format, confirmed in the final pack.
5. Label and artwork. A claims review by market, and the owner's sign-off on the name and logo before print.
6. Production. Identity tested on every lot of the branded ingredient, the branded active assayed in every finished batch, and every batch tested and released by quality control.
7. After launch. We track new studies, data protection end dates and rule changes, and propose updates.

That last step is how we work with a UK pouch brand, a client since 2023: our R&D team developed four distinct formulas for it and proposes formula updates when ingredients improve or market conditions shift.

With every batch you receive a certificate of analysis that reports the branded active against its label amount, and the batch release confirmation. From development you keep the formula, its specification, the evidence review, the stability data behind your shelf life and the signed-off artwork, ready for the ingredient owner, retailers and marketplaces.

R&D is a paid stage that can be included with an order of the right size. Your formula is yours: the formula, its specification and its data belong to your brand, while the ingredient's trade mark stays with its owner (see formula ownership). British VitaTech is ISO 9001, HACCP and GMP certified by BSI, and FDA registered, and our ingredient library lists the actives we formulate with. Start your project with the ingredient you want to build on.

References: US Federal Trade Commission, Health Products Compliance Guidance (2022); 21 U.S.C. 350b, new dietary ingredients (1994); FDA proposed rule on substances generally recognized as safe (2026); 21 CFR 111.75, dietary supplement manufacturing (2007); Regulation (EU) 2015/2283 on novel foods (2015); Regulation (EC) No 1924/2006 on nutrition and health claims (2006); Trade Marks Act 1994 (1994); Commission Implementing Regulation (EU) 2024/2694 on magnesium L-threonate (2024).